[ALLERGY PREVENTION AND TREATMENT DURING THE FIRST YEAR]

Ron Shaoul1, Miri Pevzner2, Zehavit Goldshtein3

  • 1Pediatric Gastroenterology Institute, Ruth Children's Hospital, Rambam Medical Center., Faculty of Medicine, Technion.

Harefuah
|March 22, 2021
PubMed

Insights

Exclusive breastfeeding for six months is recommended for infant allergy prevention. For non-breastfed infants at risk, hydrolyzed formulas may reduce allergy risk, while soy formulas are not recommended. Early introduction of solids is advised.

Area of Science:

  • Pediatrics
  • Allergology
  • Immunology

Background:

  • Maternal and infant nutrition significantly impacts allergy development.
  • Recent research guides infant feeding recommendations for allergy prevention.
  • Established guidelines exist for at-risk infants, including those with a family history of allergies.

Purpose of the Study:

  • To summarize current evidence-based recommendations for infant feeding and allergy prevention.
  • To inform healthcare professionals on managing infant nutrition for atopic disease risk.
  • To highlight changes in clinical practice regarding infant feeding and allergen exposure.

Main Methods:

  • Review of recent scientific literature and clinical guidelines.
  • Analysis of recommendations from European and United States healthcare bodies.
  • Synthesis of data on breastfeeding, hydrolyzed formulas, soy formulas, and solid food introduction.

Main Results:

  • Exclusive breastfeeding for 6 months is recommended for all infants.
  • Partially or fully hydrolyzed formulas may benefit non-breastfed infants at high risk of allergies.
  • Early introduction of solids (4-6 months) without allergen avoidance is recommended; delayed introduction may increase allergy risk.

Conclusions:

  • Current guidelines emphasize exclusive breastfeeding and early introduction of diverse solids.
  • Hydrolyzed formulas are a viable option for specific high-risk, non-breastfed infants.
  • Healthcare providers must stay updated on evolving infant nutrition and allergy prevention strategies.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
29.9K
Upper Respiratory Drugs: First and Second-Generation Antihistamines01:15

Upper Respiratory Drugs: First and Second-Generation Antihistamines

Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
632
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.5K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
570
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.8K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.0K